Tricontinent Scientific Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Tricontinent Scientific Inc. - overview
Established
1975
Location
Grass Valley, CA, US
Primary Industry
Medical Devices & Equipment
About
Tricontinent Scientific Inc. specializes in the manufacturing of precision syringe pumps and liquid handling robots, primarily serving biotechnology and diagnostic sectors with reliable solutions for accurate liquid dispensing. Founded in 1975 and headquartered in Grass Valley, US, Tricontinent Scientific Inc. focuses on precision liquid handling technology.
The company was acquired by Gardner Denver, a portfolio company of KKR, in May 2015, although financial terms were not disclosed. The firm has engaged in one deal to date. TriContinent is a prominent manufacturer specializing in precision syringe pumps and liquid handling robots, catering primarily to the biotechnology, diagnostics, and analytical equipment industries. Their core offerings include a variety of air-displacement and positive-displacement pumps, engineered for exceptional flow stability and accuracy for low-volume dispensing applications.
The company’s product line features rotary valves, microplate washers, dispensers, and precision pipettes, enhancing operational efficiency in laboratory settings. End users encompass major pharmaceutical companies, research laboratories, and diagnostic centers across global markets, including Europe and Asia, where reliable liquid handling solutions are essential for in-vitro diagnostics and scientific applications. Released over the years, these products continue to meet the rigorous demands of customers seeking high-precision dosing in their operations. The revenue model for TriContinent is structured around direct B2B transactions with clients, which include industry leaders in biotechnology and diagnostics.
Transactions typically occur through bulk orders of precision syringe pumps and related equipment, often under negotiated contracts that may include service agreements and support. The flagship products, such as the AccuPump2 and models in the Air-Z series, are included in these contracts, reflecting a commitment to delivering quality and reliability. Pricing plans are generally tailored to the specific needs of large-scale manufacturers and research institutions, ensuring optimal value for their investments in precision liquid handling solutions. This direct engagement with customers fosters long-term partnerships and ensures sustainability in revenue generation.
TriContinent plans to leverage recent developments and innovations to introduce new products designed to enhance liquid handling efficiency in laboratories. The company is targeting expansion into European and Asian markets by late 2016, aiming to meet the increasing demand for precision liquid handling solutions in these regions. The acquisition by Gardner Denver in May 2015 is expected to bolster these initiatives, although specific funding allocations for these growth strategies have not been disclosed.
Current Investors
Gardner Denver, Inc.
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Equipment Distributors
Website
www.tricontinent.com
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Tricontinent Scientific Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Tricontinent Scientific Inc. | - |
Displaying 1 - 1 of 1

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.